ArticleOncogene2016

Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib.

K Yonesaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.